Cargando…
A GWAS in uveal melanoma identifies risk polymorphisms in the CLPTM1L locus
Uveal melanoma, a rare malignant tumor of the eye, is predominantly observed in populations of European ancestry. A genome-wide association study of 259 uveal melanoma patients compared to 401 controls all of European ancestry revealed a candidate locus at chromosome 5p15.33 (region rs421284: OR = 1...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5542017/ https://www.ncbi.nlm.nih.gov/pubmed/28781888 http://dx.doi.org/10.1038/s41525-017-0008-5 |
_version_ | 1783254906545635328 |
---|---|
author | Mobuchon, Lenha Battistella, Aude Bardel, Claire Scelo, Ghislaine Renoud, Alexia Houy, Alexandre Cassoux, Nathalie Milder, Maud Cancel-Tassin, Géraldine Cussenot, Olivier Delattre, Olivier Besse, Céline Boland, Anne Deleuze, Jean-François Cox, David G. Stern, Marc-Henri |
author_facet | Mobuchon, Lenha Battistella, Aude Bardel, Claire Scelo, Ghislaine Renoud, Alexia Houy, Alexandre Cassoux, Nathalie Milder, Maud Cancel-Tassin, Géraldine Cussenot, Olivier Delattre, Olivier Besse, Céline Boland, Anne Deleuze, Jean-François Cox, David G. Stern, Marc-Henri |
author_sort | Mobuchon, Lenha |
collection | PubMed |
description | Uveal melanoma, a rare malignant tumor of the eye, is predominantly observed in populations of European ancestry. A genome-wide association study of 259 uveal melanoma patients compared to 401 controls all of European ancestry revealed a candidate locus at chromosome 5p15.33 (region rs421284: OR = 1.7, CI 1.43–2.05). This locus was replicated in an independent set of 276 cases and 184 controls. In addition, risk variants from this region were positively associated with higher expression of CLPTM1L. In conclusion, the CLPTM1L region contains risk alleles for uveal melanoma susceptibility, suggesting that CLPTM1L could play a role in uveal melanoma oncogenesis. |
format | Online Article Text |
id | pubmed-5542017 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-55420172017-08-03 A GWAS in uveal melanoma identifies risk polymorphisms in the CLPTM1L locus Mobuchon, Lenha Battistella, Aude Bardel, Claire Scelo, Ghislaine Renoud, Alexia Houy, Alexandre Cassoux, Nathalie Milder, Maud Cancel-Tassin, Géraldine Cussenot, Olivier Delattre, Olivier Besse, Céline Boland, Anne Deleuze, Jean-François Cox, David G. Stern, Marc-Henri NPJ Genom Med Article Uveal melanoma, a rare malignant tumor of the eye, is predominantly observed in populations of European ancestry. A genome-wide association study of 259 uveal melanoma patients compared to 401 controls all of European ancestry revealed a candidate locus at chromosome 5p15.33 (region rs421284: OR = 1.7, CI 1.43–2.05). This locus was replicated in an independent set of 276 cases and 184 controls. In addition, risk variants from this region were positively associated with higher expression of CLPTM1L. In conclusion, the CLPTM1L region contains risk alleles for uveal melanoma susceptibility, suggesting that CLPTM1L could play a role in uveal melanoma oncogenesis. Nature Publishing Group UK 2017-03-10 /pmc/articles/PMC5542017/ /pubmed/28781888 http://dx.doi.org/10.1038/s41525-017-0008-5 Text en © The Author(s) 2017 This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ |
spellingShingle | Article Mobuchon, Lenha Battistella, Aude Bardel, Claire Scelo, Ghislaine Renoud, Alexia Houy, Alexandre Cassoux, Nathalie Milder, Maud Cancel-Tassin, Géraldine Cussenot, Olivier Delattre, Olivier Besse, Céline Boland, Anne Deleuze, Jean-François Cox, David G. Stern, Marc-Henri A GWAS in uveal melanoma identifies risk polymorphisms in the CLPTM1L locus |
title | A GWAS in uveal melanoma identifies risk polymorphisms in the CLPTM1L locus |
title_full | A GWAS in uveal melanoma identifies risk polymorphisms in the CLPTM1L locus |
title_fullStr | A GWAS in uveal melanoma identifies risk polymorphisms in the CLPTM1L locus |
title_full_unstemmed | A GWAS in uveal melanoma identifies risk polymorphisms in the CLPTM1L locus |
title_short | A GWAS in uveal melanoma identifies risk polymorphisms in the CLPTM1L locus |
title_sort | gwas in uveal melanoma identifies risk polymorphisms in the clptm1l locus |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5542017/ https://www.ncbi.nlm.nih.gov/pubmed/28781888 http://dx.doi.org/10.1038/s41525-017-0008-5 |
work_keys_str_mv | AT mobuchonlenha agwasinuvealmelanomaidentifiesriskpolymorphismsintheclptm1llocus AT battistellaaude agwasinuvealmelanomaidentifiesriskpolymorphismsintheclptm1llocus AT bardelclaire agwasinuvealmelanomaidentifiesriskpolymorphismsintheclptm1llocus AT sceloghislaine agwasinuvealmelanomaidentifiesriskpolymorphismsintheclptm1llocus AT renoudalexia agwasinuvealmelanomaidentifiesriskpolymorphismsintheclptm1llocus AT houyalexandre agwasinuvealmelanomaidentifiesriskpolymorphismsintheclptm1llocus AT cassouxnathalie agwasinuvealmelanomaidentifiesriskpolymorphismsintheclptm1llocus AT mildermaud agwasinuvealmelanomaidentifiesriskpolymorphismsintheclptm1llocus AT canceltassingeraldine agwasinuvealmelanomaidentifiesriskpolymorphismsintheclptm1llocus AT cussenotolivier agwasinuvealmelanomaidentifiesriskpolymorphismsintheclptm1llocus AT delattreolivier agwasinuvealmelanomaidentifiesriskpolymorphismsintheclptm1llocus AT besseceline agwasinuvealmelanomaidentifiesriskpolymorphismsintheclptm1llocus AT bolandanne agwasinuvealmelanomaidentifiesriskpolymorphismsintheclptm1llocus AT deleuzejeanfrancois agwasinuvealmelanomaidentifiesriskpolymorphismsintheclptm1llocus AT coxdavidg agwasinuvealmelanomaidentifiesriskpolymorphismsintheclptm1llocus AT sternmarchenri agwasinuvealmelanomaidentifiesriskpolymorphismsintheclptm1llocus AT mobuchonlenha gwasinuvealmelanomaidentifiesriskpolymorphismsintheclptm1llocus AT battistellaaude gwasinuvealmelanomaidentifiesriskpolymorphismsintheclptm1llocus AT bardelclaire gwasinuvealmelanomaidentifiesriskpolymorphismsintheclptm1llocus AT sceloghislaine gwasinuvealmelanomaidentifiesriskpolymorphismsintheclptm1llocus AT renoudalexia gwasinuvealmelanomaidentifiesriskpolymorphismsintheclptm1llocus AT houyalexandre gwasinuvealmelanomaidentifiesriskpolymorphismsintheclptm1llocus AT cassouxnathalie gwasinuvealmelanomaidentifiesriskpolymorphismsintheclptm1llocus AT mildermaud gwasinuvealmelanomaidentifiesriskpolymorphismsintheclptm1llocus AT canceltassingeraldine gwasinuvealmelanomaidentifiesriskpolymorphismsintheclptm1llocus AT cussenotolivier gwasinuvealmelanomaidentifiesriskpolymorphismsintheclptm1llocus AT delattreolivier gwasinuvealmelanomaidentifiesriskpolymorphismsintheclptm1llocus AT besseceline gwasinuvealmelanomaidentifiesriskpolymorphismsintheclptm1llocus AT bolandanne gwasinuvealmelanomaidentifiesriskpolymorphismsintheclptm1llocus AT deleuzejeanfrancois gwasinuvealmelanomaidentifiesriskpolymorphismsintheclptm1llocus AT coxdavidg gwasinuvealmelanomaidentifiesriskpolymorphismsintheclptm1llocus AT sternmarchenri gwasinuvealmelanomaidentifiesriskpolymorphismsintheclptm1llocus |